Big pharma hasn’t gotten the memo about there being a bear market. Just look at Amgen. The biotechnology stock jumped to a new record high on November 8. The breakout followed a strong earnings report and data about its olpasiran cholesterol drug. It’s consolidated in a tight range since then, demonstrated by the narrowing of Bollinger Bandwidth. That may...
- $QQQ holds 7.77M shares of $AMGN - $AMGN post-earnings report outperformed the general market.
The PEAD projected a Bullish outlook for $AMGN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 71.43%.
Ascending triangle, clearing 52 week high. Look for fast move higher.
broke horizontal support Setup: NASDAQ:AMGN 1D chart enter with limit order when price pulls back - EP @ low of range SL above last pullback TP @ previous lows of Oct/Dec '21 R/R 3.7 ⚠️ watch out for potential supports @ previous levels of resistance or support (marked with orange flags) > 1:1 when hitting first support, 2:1 when hitting second, so trade...
Price is below the Bands. Rectangle and price hit the bottom trendline and it shot up a bit for now If it breaks down, targets in orange type below the rectangle structure. No recommendation. This pattern is neutral until a trendline is broken. Probably will be broken, just not today perhaps
I am now interested in $AMGN a much better setup developing now after it absorbed some of that overhead supply and created a shakeout on the 5th.
The PEAD projected a Neutral outlook for $AMGN after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 62.5%.
For a long period of time price on AMGN has been within an ascending channel This channel could be viewed as a flag of a bullflag, but we will just assume its only an ascending channel . A breakout higher out of the channel is required to continue the bull trend
Sometimes in a bear market a handful of stocks remain closer to their highs before rolling over. Amgen (AMGN) could face such a condition. The main pattern on today’s chart are the candlesticks of July 8, 11 and 12. The drugmaker attempted to push above $249 but each time closed below that level. Also notice how this price area roughly matches the closing price...
AMGN Continuation Long on the Daily . TPs and SL on the chart. Max leverage/margin or call option play.
Breakout $AMGN on volume and relative strength - equal leg target 271$
A price action above 234.55 supports a bullish trend direction. Crossing below this level will negate the bullish stance. Remains above its 200-day simple moving average. Upside price momentum supports the bullish trend. RSI leaves enough room for further upside price potential.
2d2u on the week and making it to the target will trigger the 50% rule on the month. This may be a nice swing if it can hold and keep pushing.
The PEAD projected a Bullish outlook for $AMGN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.